Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page
- Check7 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check14 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference3%
- Check35 days agoChange DetectedThe page indicates a termination for business reasons and has updated the revision number to v2.16.3, while also changing a date from May 11, 2025, to June 10, 2025.SummaryDifference2%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check50 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.